[go: up one dir, main page]

WO2004005489A3 - Nucleic acids encoding sarcocystic neurona antigen and uses thereof - Google Patents

Nucleic acids encoding sarcocystic neurona antigen and uses thereof Download PDF

Info

Publication number
WO2004005489A3
WO2004005489A3 PCT/US2003/004856 US0304856W WO2004005489A3 WO 2004005489 A3 WO2004005489 A3 WO 2004005489A3 US 0304856 W US0304856 W US 0304856W WO 2004005489 A3 WO2004005489 A3 WO 2004005489A3
Authority
WO
WIPO (PCT)
Prior art keywords
provides
nucleic acids
nucleic acid
sarcocystis neurona
encoded
Prior art date
Application number
PCT/US2003/004856
Other languages
French (fr)
Other versions
WO2004005489A2 (en
Inventor
Daniel K Howe
Original Assignee
Univ Kentucky Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kentucky Res Found filed Critical Univ Kentucky Res Found
Priority to AU2003217568A priority Critical patent/AU2003217568A1/en
Publication of WO2004005489A2 publication Critical patent/WO2004005489A2/en
Publication of WO2004005489A3 publication Critical patent/WO2004005489A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention provides novel isolated nucleic acids encoding antigenic proteins derived from Sarcocystis neurona, or unique fragments thereof In particular, the invention provides novel isolated nucleic acids encoding membrane-associated polypeptides SnSAG2, SnSAG3, and SnSAG 4. Also provided are purified antigenic polypeptide fragments encoded by the novel nucleic acid sequences set forth herein that encode for Sarcocystis neurona. In particular, the invention provides purified antigenic polypeptide fragments encoded by the novel nucleic acid sequences set forth herein that encode for SnSAG2, SnSAG3, and SnSAG 4. Further, the invention provides a purified antigenic polypeptide fragment encoded by the nucleic acid sequences set forth herein or a selective portion thereof, in a pharmaceutically acceptable carrier. Also provided isolated nucleic acids capable of selectively hybridizing with the nucleic acid from Sarcocystis neurona. The invention also provides vectors comprising the nucleic acids of the invention encoding Sarcocystis neurona or a unique fragment thereof and provides the vector in a host capable of expressing the polypeptide encoded by that nucleic acid. Finally, the invention provides a purified polyclonal and/or a monoclonal antibody specifically reactive with Sarcocystis neurona and a method of detection of Sarcocystis neurona utilizing the antibodies of the invention.
PCT/US2003/004856 2002-02-15 2003-02-19 Nucleic acids encoding sarcocystic neurona antigen and uses thereof WO2004005489A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003217568A AU2003217568A1 (en) 2002-02-15 2003-02-19 Nucleic acids encoding sarcocystic neurona antigen and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35747902P 2002-02-15 2002-02-15
US60/357,479 2002-02-15

Publications (2)

Publication Number Publication Date
WO2004005489A2 WO2004005489A2 (en) 2004-01-15
WO2004005489A3 true WO2004005489A3 (en) 2005-03-03

Family

ID=30115457

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/004856 WO2004005489A2 (en) 2002-02-15 2003-02-19 Nucleic acids encoding sarcocystic neurona antigen and uses thereof

Country Status (2)

Country Link
AU (1) AU2003217568A1 (en)
WO (1) WO2004005489A2 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] "Sarcocystis neurona EST project", XP002904286, Database accession no. (BM252380) *

Also Published As

Publication number Publication date
WO2004005489A2 (en) 2004-01-15
AU2003217568A8 (en) 2004-01-23
AU2003217568A1 (en) 2004-01-23

Similar Documents

Publication Publication Date Title
EP0784059A4 (en) Antigenic polypeptide of chlamydia pneumoniae
PL393286A1 (en) Soluble BR43x2 receptor and methods for the application thereof
WO1999055868A3 (en) Fizz proteins
CA2272573A1 (en) Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a methodof detecting auto-immune antibodies
WO2005051998A3 (en) Antibodies binding to a c-terminal fragment of apolipoprotein e
JP2003505025A5 (en)
CA2417570A1 (en) Tumor-specific t cell activation by peptide antigens
WO1999003987A3 (en) Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
WO2005084411A3 (en) Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
WO2001051635A3 (en) Novel stra6 polypeptides
WO2001085782A3 (en) Fusion receptor from TNF family
NZ547629A (en) Antibodies binding to conformationally discriminating epitopes of human IGG Fc receptor IIb and IIb
WO2003018797A3 (en) Method and device for integrated protein expression, purification and detection
WO2000053742A3 (en) Polynucleotides and proteins encoded thereby
AU7737091A (en) Immunodiagnostic assay for rheumatoid arthritis
EP0863153A3 (en) Foam proteins, monoclonal antibodies thereto, and their uses
WO2004005489A3 (en) Nucleic acids encoding sarcocystic neurona antigen and uses thereof
EP1094080A3 (en) Anti-dnase-gamma antibody, and production and use thereof
AU9629498A (en) Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus
WO1999057277A3 (en) Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
WO2000061754A3 (en) Human proteins and polynucleotides encoding them
WO1999063093A3 (en) Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
PT1366161E (en) Antagonist anti-pro842 antibody
EP1304375A1 (en) Method of preparing antibody by gene immunization
EP0985931A3 (en) Recombinant antigen immunoassay for the diagnosis of syphilis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP